WEBVIEW EPRO Trademark

Trademark Overview

On Wednesday, November 14, 2018, a trademark application was filed for WEBVIEW EPRO with the United States Patent and Trademark Office. The USPTO has given the WEBVIEW EPRO trademark a serial number of 88193632. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 18, 2021. This trademark is owned by Amarex Clinical Research LLC. The WEBVIEW EPRO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services
webview epro

General Information

Serial Number88193632
Word MarkWEBVIEW EPRO
Filing DateWednesday, November 14, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 18, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Disclaimer with Predetermined Text"EPRO"
Goods and ServicesPharmaceutical drug development services
Pseudo MarkWEB VIEW E PRO

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, December 1, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmarex Clinical Research LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGermantown, MD 20874
Party NameAmarex Clinical Research LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGermantown, MD 20874

Trademark Events

Event DateEvent Description
Tuesday, January 19, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 18, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 9, 2020EXTENSION 2 GRANTED
Thursday, June 18, 2020EXTENSION 2 FILED
Thursday, October 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 20, 2020NOTICE OF REVIVAL - E-MAILED
Thursday, August 20, 2020EXTENSION RECEIVED WITH TEAS PETITION
Thursday, August 20, 2020PETITION TO REVIVE-GRANTED
Thursday, August 20, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, July 20, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 20, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2019EXTENSION 1 GRANTED
Tuesday, December 17, 2019EXTENSION 1 FILED
Tuesday, December 17, 2019TEAS EXTENSION RECEIVED
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 19, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 18, 2019ASSIGNED TO LIE
Tuesday, February 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 22, 2019EXAMINER'S AMENDMENT ENTERED
Friday, February 22, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 22, 2019EXAMINERS AMENDMENT E-MAILED
Friday, February 22, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 19, 2019ASSIGNED TO EXAMINER
Saturday, December 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 17, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

epro webview services development drug pharmaceutical